Severe aortic stenosis (AS) carries a poor prognosis with the onset of heart failure (HF) symptoms, and surgical or transcatheter aortic valve replacement (AVR) is its only definitive treatment. The management of AS has seen a paradigm shift with the adoption of transcatheter aortic valve replacement (TAVR), allowing for the treatment of AS in patients who would not otherwise be candidates for surgical AVR. Despite improving long-term survival after TAVR in recent years, residual HF symptoms and HF hospitalization are common and are associated with an increased mortality and a poor health status. This review article summarizes the incidence and risk factors for HF after AVR. Strategies for preventing and better managing HF after AVR are necessary to improve outcomes in this patient population. Extensive research is underway to assess whether earlier timing for AVR, prior to the development of severe symptomatic AS and associated extra-valvular cardiac damage, can improve post-AVR patient outcomes.
The acute management of patients presenting with electrical storm secondary to ventricular arrhythmias (VAs) can be quite challenging, even with traditional attempts at rhythm control. Novel approaches are necessary to incorporate contemporary diagnostic investigations and therapeutic interventions to improve outcomes. Endomyocardial biopsy is an important but underutilised diagnostic tool that can rapidly guide the selection of tailored interventions, such as cardiac transplantation and other non-pharmacological interventions, to maximise survival. In our case, a previously healthy woman in her early 50s was hospitalised for symptomatic, pleomorphic ventricular tachycardia. Early rhythm control was achieved, but VAs recurred, consistent with electrical storm. Cardiac MRI demonstrated biventricular patchy fibrosis and late gadolinium enhancement. Endomyocardial biopsy confirmed giant cell myocarditis. She continued to deteriorate, developing cardiogenic shock requiring extracorporeal membrane oxygenation followed by urgent cardiac transplantation, eventually making a full recovery. We propose a contemporary algorithm for the management of electrical storm to maximise survival.
Intramural ventricular tachycardia represents a formidable frontier in catheter ablation, where the arrhythmogenic substrate resides deep within the myocardial wall, often beyond the reach of conventional energy delivery. Achieving durable lesion formation in this setting requires a strategic balance between transmural efficacy and procedural safety. This review synthesizes the evolving landscape of intramural ventricular tachycardia ablation, detailing contemporary techniques, including bipolar ablation, needle-based approaches, simultaneous endocardial–epicardial delivery, and emerging energy modalities, each tailored to overcome the limitations of lesion depth and tissue heterogeneity. We examine diagnostic criteria, imaging adjuncts, and electroanatomic mapping strategies that guide procedural planning and highlight innovations aimed at enhancing lesion depth without compromising adjacent structures. By integrating current evidence and expert practice, this article offers a comprehensive framework for navigating the complexities of intramural ventricular tachycardia ablation and advancing outcomes in this challenging domain.
Intramural ventricular tachycardia represents a formidable frontier in catheter ablation, where the arrhythmogenic substrate resides deep within the myocardial wall, often beyond the reach of conventional energy delivery. Achieving durable lesion formation in this setting requires a strategic balance between transmural efficacy and procedural safety. This review synthesizes the evolving landscape of intramural ventricular tachycardia ablation, detailing contemporary techniques, including bipolar ablation, needle-based approaches, simultaneous endocardial–epicardial delivery, and emerging energy modalities, each tailored to overcome the limitations of lesion depth and tissue heterogeneity. We examine diagnostic criteria, imaging adjuncts, and electroanatomic mapping strategies that guide procedural planning and highlight innovations aimed at enhancing lesion depth without compromising adjacent structures. By integrating current evidence and expert practice, this article offers a comprehensive framework for navigating the complexities of intramural ventricular tachycardia ablation and advancing outcomes in this challenging domain.